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A corrigendum on
Impact of kinase activating and inactivating patient mutations on binary PKA interactions
by Röck, R., Mayrhofer, J. E., Bachmann, V., and Stefan, E. (2015). Front. Pharmacol. 6:170. doi:
10.3389/fphar.2015.00170
Reason for Corrigendum:
There was a mistake in the figure legend for Figure 5 as published. The correct version of the
figure legend (Figure 5B) appears below. The authors apologize for the mistake. This error does
not change the scientific conclusions of the article in any way.
Figure 5. Impact of RIa mutations and cAMP elevation on PKA type I complexes. . . . (B)
Following indicated modifications of RIa-F[1] sequences, combinations of wild type and mutant
Rluc PCA tagged PKA subunits have been subjected to Rluc PCA measurements. The effect of
isoproterenol (1µM, 10min; 48 h transient PCA reporter expression) on PKA complex formation
has been determined (at least n = 3 independent experiments,±SEM).
The original article was updated.
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